JPRN-jRCTs042220078已完成2 期
Verification of safety and efficacy in distinguishing mild cognitive impairment and dementia using magnetoencephalography during optic flow stimulation
Ono Kenjiro0 个研究点目标入组 0 人开始时间: 2022年10月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
Because of lack of research fundings, we could not continue the research, and decide to abort the research programs. There were no participants, therefore, we could not get any data.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 65age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Primary registration
- •[I] A full medical checkup examinee
- •[II] Patients with MCI due to AD at Kanazawa university hospital
- •[III] Patients with AD dementia at Kanazawa university hospital
- •Secondary registration
- •[IV] Cognitively unimpaired [CU] group
- •[V] AD-MCI group
- •[VI] AD group
- •[I] A full medical checkup examinee
- •[i] Age greater than 65 years
- •[ii] Individuals who have a full medical checkup at Kanazawa Advanced Medical Center
- •[iii] Written informed consent was obtained from the participant
- •[II] Patients with MCI due to AD at Kanazawa university hospital
- •[i] Age greater than 65 years
- •[ii] Diagnosis of probable mild cognitive impairment [MCI] due to Alzheimer's disease [AD] with high evidence of the pathophysiological process, according to the criteria of the National Institute on Aging Alzheimer's Association Workgroup [NIAAA].
- •[iii] Written informed consent ans assent were obtained from the legal representative and the patient, respectively.
- •[III] Patients with AD dementia at Kanazawa university hospital
- •[i] Age greater than 65 years
- •[ii] Diagnosis of probable AD dementia with high evidence of the pathophysiological process, according to the criteria of the National Institute on Aging Alzheimer's Association Workgroup [NIAAA].
- •[iii] Written informed consent ans assent were obtained from the legal representative and the patient, respectively.
- •[IV] Cognitively unimpaired [CU] group
- •[i] A full medical checkup examinee at the primary registration
- •[ii] Diagnosed as cognitive unimpaired by the investigators
- •[V] AD-MCI group
- •[i] Out patients of Kanazawa university hospital at the primary registration
- •[ii] Diagnosed as MCI due to AD by the investigators
- •[VI] AD group
- •[i] Out patients of Kanazawa university hospital at the primary registration
- •[ii] Diagnosed as AD dementia by the investigators
排除标准
- •Primary registration
- •[I] A full medical checkup examinee
- •[II] Patients with MCI due to AD at Kanazawa university hospital
- •[III] Patients with AD dementia at Kanazawa university hospital
- •Secondary registration
- •[IV] Cognitively unimpaired [CU] group
- •[V] AD-MCI group
- •[VI] AD group
- •[I] A full medical checkup examinee
- •[i] Individuals who is unable to take an MRI scan, such as a claustrophobia or having any kind of metal in the body
- •[ii] Assessed as inappropriate to join the clinical trial by the investigator
- •[II] Patients with MCI due to AD at Kanazawa university hospital
- •[i] Individuals who is unable to take an MRI scan, such as a claustrophobia or having any kind of metal in the body
- •[ii] Assessed as inappropriate to join the clinical trial by the investigator
- •[III] Patients with AD dementia at Kanazawa university hospital
- •[i] Individuals who is unable to take an MRI scan, such as a claustrophobia or having any kind of metal in the body
- •[ii] Assessed as inappropriate to join the clinical trial by the investigator
- •[IV] Cognitively unimpaired [CU] group
- •[i] Assessed as inappropriate by the investigator
- •[V] AD-MCI group
- •[i] Individuals who have a full medical checkup at Kanazawa Advanced Medical Center
- •[ii] Assessed as inappropriate by the investigator
- •[VI] AD group
- •[i] Individuals who have a full medical checkup at Kanazawa Advanced Medical Center
- •[ii] Assessed as inappropriate by the investigator
研究者
相似试验
已完成
不适用
A prospective feasibility study of cord blood transplant using once daily intravenous busulfan and fludarabine plus melphalan as conditioning regimeHematological malignancyJPRN-UMIN000030308Osaka International Cancer Institute
已完成
不适用
Intra-retinal arterial fibrinolysisCentral retinal artery occlusionJPRN-jRCTs031180441Kadonosono Kazuaki3
已完成
2 期
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients with Respiratory Syncytial Virus (RSV) InfectioJPRN-jRCT2031210527akama Takahiro5
已完成
4 期
Efficacy of coronary artery calcification on DenosumabPatients with osteoporosis with coronary artery calcificationosteoporosis, coronary artery calcificationJPRN-jRCT1031190025Kubota Naoki1
终止
1 期
Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate MofetilLupus NephritisNCT01369628EMD Serono1